
Xellia Pharmaceuticals, a manufacturer of specialty anti-infective treatments, has become a member of Medicines for Europe. Medicines for Europe represents …

Anti-infective treatment provider Xellia has acquired Fresenius Kabi’s dedicated freeze-dried vial manufacturing facility in the US. The deal also includes …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

